Diversified pharmaceutical company with divisions
for novel medicines and complex generics
KYOJIN PARK
· Co-founder & Partner at MedCI LLC (Santa Clara, CA, USA)
· Business Consultant, Univ. of Michigan Hospital International Patient Center
· Business Consultant, Trinity Health System
· MBA, University of Michigan
WEONBIN IM
MANISH SINGHAL
· Co-Founder & Partner at MedCI LLC (Santa Clara, CA, USA)
· Practicing in internal medicine at Stanford University Hospital
· Director, Marketing, Xolan Technologies
· MD, University of Texas at San Antonio
· MBA, University of Michigan
SO-YOUNG EUN
· Chief of Business Center, R&D, AprilBio
· Senior Research Scientist, Immuno-Oncology, MOGAM Institute
· Post-Doc, La Jolla Institute for Allergy and Immunology
· PhD, Immunology from University of North Carolina at Chapel Hill
EOK PARK
· Director, Research & Development, QuBESTBio / MitoImmune Therapeutics
· Senior Researcher, Life Sciences New Drug Research Center, LG Chem
· MS, Virology from Sogang University
KANGSEOK YOON
· Head of Business strategy team, YMTECH
· Head of the management planning team,
Chungcheongnam-do Economic Promotion Agency
· BL , Department of Law from Sungkyunkwan University
· MBA , Chungbuk National University Graduate School of Business
Bernie Huyghe PhD
· Biologics CMC consultant
· Specialties in outsourcing/virtual development, contract negotiations, due diligence, supply chain, process development, analytical development, CMC regulatory submissions
· Senior Director, Pfizer
· PhD, Biophysical Chemistry, University of California, Berkeley
Jeremy Semrau PhD
· Professor, Department of Civil & Environmental Engineering, University of Michigan
· Research on methanotrophs over 20 years
· Principal investigator and co‐inventor of methanobactin
· Over 100 publications and patents
· PhD, Environmental Engineering Science, California Institute of Technology
Alan DiSpirito PhD
· Professor, Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University
· Internationally recognized expert in methanotrophy (physiology/biochemistry)
· Principal investigator and co‐inventor of methanobactin
· Over 125 publications and patents
· PhD, Microbiology, Ohio State University
Hans Zischka PhD
· Professor, Technical University Munich, Institute for Toxicology and Environmental Hygiene
· Group leader, Helmholtz Zentrum Munchen Molecular Toxicology & Pharmacology
· Over 80 publications and patents
· Investigator of methanobactin for Wilson’s Disease
· PhD, Biochemistry, University of Tubingen